Search
for

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

    Learn

    4 / 800 results

      learn Minoxidil

      Vasodilator used on the scalp and, at low doses, as a tablet
      • Minoxidil 2%, 5% and 10% which is better to use? In a randomized trial in men, 5% topical minoxidil produced more hair growth than 2%, and in one small trial 10% did not beat 5% and caused more irritation. No 10% product is approved in the US, and approved strengths differ by sex, so check the label for your product.

      learn procapil

      • Does Procapil block DHT without affecting hormones? What the evidence shows Procapil's supplier describes it as inhibiting 5-alpha reductase at the scalp without changing hormone levels, but the published support is cell and animal work plus one small human study of a caffeine-plus-Procapil formula. It is a cosmetic ingredient, not an approved hair-loss treatment, and no trial has compared it with finasteride or minoxidil.

      learn Azelaic Acid

      • Is azelaic acid a treatment on its own or does it need supplements? One small randomised trial (26 women, no placebo) found no significant difference between 5% azelaic acid and 2% minoxidil in female pattern hair loss, which is too small to show they work equally well, and the anti-DHT rationale otherwise rests on in-vitro work. Community members generally describe azelaic acid as an add-on to minoxidil or finasteride rather than a standalone treatment.
      • azelaic acid: Does it work for all types of hair loss or just DHT? One small randomised trial (26 women, no placebo) found no significant difference between 5% azelaic acid and 2% minoxidil for female pattern hair loss, which is too small to show they work equally well, and the anti-DHT rationale rests on laboratory work. For alopecia areata, telogen effluvium and seborrhoeic dermatitis there is no trial evidence for azelaic acid at all.

      learn Caffeine

      • Does caffeine stimulate hair growth or only slow hair loss? Caffeine stimulates hair follicles in laboratory cultures, and one open-label, manufacturer-funded trial in 210 men found a 0.2% caffeine topical non-inferior to minoxidil 5% on an anagen-ratio endpoint. A 2025 systematic review found only a few small controlled trials, mostly rated low or very low quality, and none in alopecia areata.